Highlights
NASDAQ: EYEG       Eyegate Pharma
Last Price Today's Change   Day's Range   Trading Volume
6.70   -0.20 (2.90%)  6.58 - 6.96  44,200

Overview

 
Avg Volume (4 weeks):988,873
4 Weeks Range:4.40 - 9.50
4 Weeks Price Volatility (%):
45.10%
52 Weeks Range:0.15 - 9.50
52 Weeks Price Volatility (%):
70.05%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Eyegate Pharmaceuticals Inc is a US-based clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. The company’s lead product EGP-437 incorporates a reformulated topically active corticosteroid, Dexamethasone Phosphate, that is delivered into the ocular tissues through proprietary drug delivery system, the EyeGate II Delivery System. It mainly develops EGP-437 for the treatment of various inflammatory conditions of the eye, including the treatment of ocular inflammation and pain in post-surgical cataract patients and uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and ciliary body.

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers